Gary W. Arendash, Ph.D.

Professor Emeritus

CONTACT

Office: ISA 2015
Phone: (480) 395-1481
Website:
Email: arendash@usf.edu

EDUCATION

  • B.S., Biology and Chemistry, San Diego State University
  • Ph.D., Physiology/Neuroscience, University of California San Francisco
  • Post-doctoral, UCLA Brain Research Institute

RESEARCH

My research has focused on development of therapeutics to prevent and treat Alzheimers Disease (AD), as well as extension of human longevity through lessening age-related diseases. My USF colleagues and I have developed and performed both pre-clinical and clinical studies with a new bioengineered technology Transcranial Radiofrequency Wave Treatment (TRFT; a.k.a. TEMT). TRFT delivers radiofrequency waves at a specific, safe frequency (1 GHz) to the entire human brain; this, as administered through a head device that provides at-home 1-hour self-treatments.
Despite decades of research, AD remains one of the most terrifying diseases of aging, with no intervention approved by FDA to prevent, stop, or reverse the diseases cognitive decline. Since 2019, however, we have published small clinical studies showing that TRFT can stop and reverse ADs cognitive decline. These benefits appear to occur through multiple mechanisms of action, including TRFTs ability to: 1) disaggregate and removal toxins from the human brain, 2) enhance brain energy production as a mitochondrial enhancer, and 3) decrease both brain and body inflammation by re-balancing the immune systems cytokines. This third mechanism appears to be particularly important since most diseases of aging (e.g., degenerative brain diseases, cancer, cardiovascular disease) have inflammation at their core. My central maxim is that TRFT should reduce the risk/severity of many age-related diseases especially by rejuvenating the immune system. Most recently, I have reported our pre-clinical and clinical evidence that the human brain may process and store memories as a quantum computer a computer that is actually made up of billions of mini computers within neurons called microtubules. These microtubules vibrate at around 1 GHz, which appears to induce biophoton production within them, leading to increased numbers and discrete patterns of quantum Super Position Qubits (SPQs) in microtubule walls. It is these SPQs that may be responsible for human consciousness and memory storage.

Current Research

My current research interests continue to involve TRFT and are three-fold. First, to further establish the ability of TRFT to prevent/reverse Alzheimers cognitive impairment and associated biomarker/brain imaging changes through larger controlled Phase 2b/III clinical trials in AD subjects. Second, to perform controlled clinical trials with TRFT in normal aged humans to determine TRFTs ability to extend healthy longevity by: 1) decreasing/reversing markers of aging and inflammation in blood and brain, 2) maintaining/improving cognitive performance, and 3) slowing or stopping age-related changes observed in brain imaging (e.g., PET, MRI, fMRI scans). And third, to gain further evidence that the human brain functions as a quantum computer for memory and cognition via neuronal microtubules. Accomplishing these goals involves inter-disciplinary collaborations across molecular bioscience, cognitive neuroscience, brain imaging, biophysics, clinical science, neurology, and physiology.   

Recent laboratory papers

  • Arendash, G. Neuronal Microtubules and Radiofrequency Waves: The Quantum Core of Human Consciousness, Memory, and Pathway to Memory Enhancement/Recovery. International Journal of Molecular Sciences 27: 6090 (2026).
  • Arendash, G. The Evidence That Brain Cancers Could Be Effectively Treated with In-Home Radiofrequency Waves. Cancers 17: 2665 (2025).
  • Arendash, G. The Brain Toxin Cleansing of Sleep Achieved During Wakefulness. Journal of Clinical Medicine 14: 926 (2025).
  • Baranowski, R., Amschler, J., Wittwer, D., and G. Arendash. Human Memory Enhancement by Transcranial Radiofrequency Wave Treatment Occurs Without Appreciably Increasing Brain Temperature. Physics and Engineering Science in Medicine. doi:10.1007/s13246-024- 01508 (2025)
  • Arendash, G., Lin, X., and Cao, C. Enhanced Brain Clearance of Tau and A-beta by Transcranial Radiofrequency Wave Treatment: A Central Role of VEGF. Journal of Alzheimers Disease 100100:S223-S241 (2024).
  • Arendash, G., and C. Cao, Transcranial Electromagnetic Wave Treatment: A Fountain of Healthy Longevity? International Journal of Molecular Sciences 24: 9652 (2023).
  • Arendash, G., Abulaban, H., Steen, S., Andel, R., Wang, Y., Bai, Y., Baranowski, R., McGarity, J., Scritsmier, L., Lin, X., Shen, N., Aljassabi, A., Li, Y., and C. Cao, Transcranial Electromagnetic Treatment Stops Alzheimers Disease Cognitive Decline Over a 2翻 Year Period: A Pilot Study. Medicines, Vol. 9, August 3 (2022).
  • Cao, C., Abulaban, H., Baranowski, R., Wang, Y., Bai, I., Lin, X., Shen, N., Zhang, X., and G. Arendash. Transcranial Electromagnetic Treatment Rebalances Blood and Brain Cytokine Levels in Alzheimers Patients: A New Mechanism for Reversal of Their Cognitive Impairment. Frontiers in Aging Neuroscience: 14, Article 829049 (2022).
  • Arendash, G., Cao, C., Abulaban, H., Baranowski, R., Wisniewski, G., Becerra, L., Andel, R., Lin, X., Zhang X., Wittwer, D., Moulton, J., Arrington, J., and A. Smith. A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimers Disease: Cognitive Enhancement and Associated Changes in CSF, Blood, and Brain Imaging. Journal of Alzheimers Disease Vol 71: 57-82 (2019).